The health impact fund: how to make new medicines accessible to all

, &
In S. R. Benatar & Gillian Brock (eds.), Global Health and Global Health Ethics. Cambridge University Press. pp. 241--250 (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Health Impact Fund and the Right to Participate in the Advancement of Science.Cristian Timmermann - 2012 - European Journal of Applied Ethics 1 (1).
A Critique in Need of Critique.M. Peterson, A. Hollis & T. Pogge - 2010 - Public Health Ethics 3 (2):178-185.
Responsibilities for Global Health: The Efficiency of the Health Impact Fund?V. Paivansalo - 2009 - Public Health Ethics 2 (1):100-104.
Global justice considerations for a proposed “climate impact fund”.Cristian Timmermann & Henk van den Belt - 2012 - Public Reason 4 (1-2):182-196.
The health impact fund: A useful supplement to the patent system?Aidan Hollis - 2008 - Public Health Ethics 1 (2):124-133.
Global Health and Global Health Ethics.Solomon Benatar & Gillian Brock (eds.) - 2011 - Cambridge University Press.
The health impact fund and its justification by appeal to human rights.Thomas Pogge - 2009 - Journal of Social Philosophy 40 (4):542-569.
Intellectual property and global health: from corporate social responsibility to the access to knowledge movement.Cristian Timmermann & Henk van den Belt - 2013 - Liverpool Law Review 34 (1):47-73.
The Health Impact Fund: Boosting Pharmaceutical Innovation Without Obstructing Free Access.Thomas Pogge - 2009 - Cambridge Quarterly of Healthcare Ethics 18 (1):78.
Three proposals for rewarding novel health technologies benefiting people living in poverty. A comparative analysis of prize funds, health impact funds and a cost-effectiveness/competitive tender treaty.Thomas Alured Faunce & Hitoshi Nasu - 2008 - Public Health Ethics 1 (2):146-153.
Incentivizing access and innovation for essential medicines: A survey of the problem and proposed solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.
Binding Market and Mission: Pharmaceuticals for the World's Poor.Daniele Botti - 2013 - Solutions 4 (1).
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.

Analytics

Added to PP
2014-01-27

Downloads
16 (#883,649)

6 months
1 (#1,510,037)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Thomas W. Pogge
Yale University
Gillian Brock
University of Auckland

Citations of this work

Contemporary Cosmopolitanism: Some Current Issues.Gillian Brock - 2013 - Philosophy Compass 8 (8):689-698.

Add more citations

References found in this work

No references found.

Add more references